Recent Updates
Recently added Catalysts
MLTX Negative Sentiment Score: 15/100

MOONLAKE ALERT: Bragar Eagel & Squire, P.C. Announces Investigation into MoonLake Immunotherapeutics on Behalf of MoonLake Stockholders and Encourages Investors to Contact the Firm

Key Takeaway: Bragar Eagel & Squire, P.C. has launched an investigation into MoonLake Immunotherapeutics following significant stock losses experienced by investors. This investigation is prompted by the company's recent announcement regarding its VELA-2 trial, which failed to achieve statistical significance. On September 29, 2025, the stock dropped 89.9%, raising questions about potential violations of federal securities laws and business practices. Investors who have incurred losses are encouraged to reach out to the firm for more information on their legal options.

Market Sentiment Analysis

CONCERNS & RISKS

  • MoonLake stock plummeted 89.9% on September 29, 2025, after disappointing trial results.
  • The company is under investigation for potential violations of federal securities laws.
  • There are concerns regarding unlawful business practices conducted by MoonLake.

Full Press Release Details

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In MoonLake (MLTX) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Moon Lake and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) --
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ:MLTX) on behalf of MoonLake stockholders. Our investigation concerns whether MoonLake has violated the federal securities laws and/or engaged in other unlawful business practices.
Investigation Details:
On September 29, 2025, before the market opened, MoonLake Immunotherapeutics filed with the SEC a current report on Form 8-K. Attached to the current report was a press release which stated that, in MoonLake’s VELA-2 trial, “intercurrent events in the higher-than-expected placebo arm precluded the study from achieving statistical significance in the week 16 primary endpoint using the composite strategy[.]”
On this news, MoonLake stock plummeted 89.9% on September 29, 2025.
If you purchased or otherwise acquired MoonLake shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.

Tags

MoonLake Immunotherapeutics
Bragar Eagel & Squire

Frequently Asked Questions

How can I contact Bragar Eagel & Squire about my losses?

You can reach Brandon Walker or Marion Passmore at (212) 355-4648.

Why is Bragar Eagel & Squire investigating MoonLake?

The firm is investigating potential violations of federal securities laws by MoonLake.

What happened to MoonLake stock on September 29, 2025?

MoonLake stock dropped 89.9% after an unfavorable trial report was released.

Is there a cost to discuss my legal rights with the firm?

No, there is no cost or obligation to discuss your legal rights.

Where is Bragar Eagel & Squire located?

The firm has offices in New York, South Carolina, and California.

Last updated: Oct 2, 2025